FDA Approved: ABREVA — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for ABREVA (docosanol) submitted by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Labialis

Drugs mentioned

• ABREVA (Docosanol)

Snippet

SUPPL AP for ABREVA (DOCOSANOL)